ACOXL
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| acyl-CoA oxidase like | Ensembl:ENSG00000153093 | HGNC:HGNC:25621 | PA134932567 | 2q13 |
GO terms in ACOXL
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | ND | GO:0005575 | cellular_component |
| CC | IBA | GO:0005777 | peroxisome |
| CC | TAS | GO:0005782 | peroxisomal matrix |
| BP | ND | GO:0008150 | biological_process |
| BP | IBA | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
| BP | IBA | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase |
| BP | TAS | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase |
| BP | IBA | GO:0055088 | lipid homeostasis |
| MF | ND | GO:0003674 | molecular_function |
| MF | IBA | GO:0003995 | acyl-CoA dehydrogenase activity |
| MF | IBA | GO:0003997 | acyl-CoA oxidase activity |
| MF | IBA | GO:0005504 | fatty acid binding |
| MF | TAS | GO:0016402 | pristanoyl-CoA oxidase activity |
| MF | IBA | GO:0050660 | flavin adenine dinucleotide binding |
Gene expression in normal tissue: ACOXL
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ACOXL
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1430728 | Metabolism |
| reactome | R-HSA-389887 | Beta-oxidation of pristanoyl-CoA |
| reactome | R-HSA-390918 | Peroxisomal lipid metabolism |
| reactome | R-HSA-556833 | Metabolism of lipids |
| reactome | R-HSA-8978868 | Fatty acid metabolism |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD532 | Olaparib | 3 |
| iGMDRD116 | CD437 | 2 |
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD154 | NSC23766 | 3 |
| iGMDRD945 | ML214 | 3 |
| iGMDRD123 | Isoevodiamine | 4 |
| iGMDRD901 | ELCPK | 3 |
| iGMDRD237 | ABT-751 | 2 |
| iGMDRD481 | Dactolisib | 2 |
| iGMDRD289 | Parthenolide | 3 |
| iGMDRD271 | Brefeldin A | 2 |
| iGMDRD158 | NSC141540 | 3 |
| iGMDRD82 | Quiflapon | 1 |
| iGMDRD147 | Prima-1 | 2 |
| iGMDRD246 | NPC26 | 1 |
| iGMDRD300 | Tozasertib | 6 |
| iGMDRD329 | Merck60 | 3 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD144 | NSC95397 | 2 |
| iGMDRD546 | BMS-754807 | 2 |
| iGMDRD1008 | SR-II-138A | 3 |
| iGMDRD889 | Compound 7d-cis | 5 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD193 | Fqi1 | 1 |
| iGMDRD201 | SKI II | 2 |
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD187 | BRD9876 | 3 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 6 |
| iGMDRD782 | DC-45-A2 | 2 |
| iGMDRD255 | SB225002 | 5 |
| iGMDRD138 | PX 12 | 6 |
| iGMDRD270 | Ciclosporin | 2 |
| iGMDRD513 | BML-259 | 1 |
| iGMDRD356 | PNU-74654 | 2 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD690 | PRIMA-1MET | 6 |
| iGMDRD399 | Selumetinib | 2 |
| iGMDRD188 | Piperlongumine | 6 |
| iGMDRD100 | Zebularine | 6 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ACOXL
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.